These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 34671639)
1. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment. Xu Z; Jiang S; Ma J; Tang D; Yan C; Fang K Front Surg; 2021; 8():742360. PubMed ID: 34671639 [No Abstract] [Full Text] [Related]
2. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma. Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y Front Surg; 2022; 9():860806. PubMed ID: 35937602 [TBL] [Abstract][Full Text] [Related]
3. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer. Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517 [TBL] [Abstract][Full Text] [Related]
4. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients. Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304 [No Abstract] [Full Text] [Related]
5. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y Front Genet; 2022; 13():787884. PubMed ID: 35350243 [No Abstract] [Full Text] [Related]
6. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. Cui Y; Zhou Z; Chai Y; Che X; Zhang Y J Oncol; 2021; 2021():8533464. PubMed ID: 34484338 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J Front Immunol; 2022; 13():922315. PubMed ID: 35774794 [TBL] [Abstract][Full Text] [Related]
8. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954 [TBL] [Abstract][Full Text] [Related]
9. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer. Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433 [No Abstract] [Full Text] [Related]
10. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
11. Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs. Peng L; Ji J; Zhang C; Wu Z; Sun Y; Fan K; Du W; Liu A; Jiao W J Thorac Dis; 2022 Oct; 14(10):3955-3974. PubMed ID: 36389299 [TBL] [Abstract][Full Text] [Related]
12. The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer. Liu C; Gao Y; Ni J; Chen S; Hu Q; Wang C; Hu M; Chen M BMC Cancer; 2022 Jul; 22(1):788. PubMed ID: 35850679 [TBL] [Abstract][Full Text] [Related]
13. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer. Wang Y; Xu Y; Zhang Y Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765 [TBL] [Abstract][Full Text] [Related]
14. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs. Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740 [TBL] [Abstract][Full Text] [Related]
15. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
16. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
17. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ Front Oncol; 2021; 11():738477. PubMed ID: 34568075 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. Ju L; Shi Y; Liu G PeerJ; 2022; 10():e14506. PubMed ID: 36570012 [TBL] [Abstract][Full Text] [Related]
19. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
20. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]